GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 3,168 | 3,122 | 3,621 | 3,665 | 5,778 |
| Operating Income | -3,168 | -3,122 | -3,621 | -3,665 | -5,778 |
| Interest Expense | 0 | 0 | 1 | 212 | 0 |
| Other Income | 206 | 706 | 1,630 | 3,650 | 194 |
| Pre-tax Income | -2,962 | -2,416 | -1,992 | -227 | -5,584 |
| Net Income Continuous | -2,962 | -2,416 | -1,992 | -227 | -5,584 |
| Net Income | $-2,962 | $-2,416 | $-1,992 | $-227 | $-5,584 |
| EPS Basic Total Ops | -2.04 | -1.80 | -1.50 | -0.30 | -4.95 |
| EPS Basic Continuous Ops | -2.20 | -1.77 | -1.49 | -0.17 | -5.19 |
| EPS Diluted Total Ops | -2.04 | -1.80 | -1.50 | -0.30 | -4.95 |
| EPS Diluted Continuous Ops | -2.20 | -1.77 | -1.49 | -0.17 | -5.19 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.80 | -2.70 | -2.40 | -5.41 |
| EBITDA(a) | $-3,168 | $-3,122 | $-3,621 | $-3,665 | $-5,778 |